Results 121 to 130 of about 3,014 (182)

Foxs1-mediated transformation of CD34⁺ fibroblast to myCAFs promotes tumor growth. [PDF]

EMBO Mol Med
Yang J, Chen T, Zhang R, Xu J, Zhao X, Yang M, Chen Z, Sun S, Chen X, Zhang S, Jiang L, Zheng Y, Hu Y, Xu Q, Lin W, Shen L, Zhang L.   +16 more
europepmc   +1 more source

Editorial: Innovative molecular therapeutic approaches in urothelial carcinoma

Frontiers in Oncology
Sheldon L. Holder, Ming Yin, Monika Joshi   +2 more
doaj   +1 more source

Real-world treatment patterns in men with metastatic hormone-sensitive prostate cancer in Europe and Asia between 2020 and 2024. [PDF]

Oncologist
Raval AD, Mpima S, Casey V, Manuguid F, Korn M, Castro E.   +5 more
europepmc   +1 more source

Editorial Comment to Immune Checkpoint Inhibitor Retreatment after Enfortumab Vedotin in Advanced Urothelial Carcinoma: A Descriptive Study with Exploratory Evaluation of Radiotherapy. [PDF]

JMA J
Miyakawa J.
europepmc   +1 more source

The Role of FGFR3 in the Progression of Bladder Cancer. [PDF]

Cancers (Basel)
Ninomiya S, Ishiguro Y, Hasumi H, Jikuya R, Hashizume A, Yamazaki M, Teranishi JI, Makiyama K, Uemura H, Miyamoto H, Kawahara T.   +10 more
europepmc   +1 more source

The clinical landscape of bladder cancer treatment: a brief report on new developments and future perspectives in pharmaceutical interventions. [PDF]

Front Oncol
Xu X, Hao HY, Chen HY.
europepmc   +1 more source

Sphingosine-1-Phosphate Receptor 3 Confers Tumor Metastasis in Lung Cancer Resistant to Third-Generation EGFR Inhibitor. [PDF]

MedComm (2020)
Lai M, Chen J, Qin Y, Zhang H, Pan Z, Zhang T, Tong L, Tang H, Bai G, Liu Q, Li Y, Feng F, Song P, Liu Y, Chen Y, Fang Y, Tang B, Geng M, Yu K, Chen H, Ding J, Xie H.   +21 more
europepmc   +1 more source

Advances in immunotherapy for bladder cancer and clinical practice of next-generation sequencing. [PDF]

Front Immunol
Ning W, Chang P, Zheng J, Chen W.
europepmc   +1 more source

Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young. [PDF]

Mol Cancer Ther
Fordham AM, Brown LM, Mayoh C, Salib A, Barger ZA, Wong M, Lim Kam Sian TCC, Hu C, Xie J, Gunther K, Trebilcock P, Terry RL, Barahona P, Ajuyah P, Sherstyuk A, Avila A, Cadiz R, Perkins CM, Gifford AJ, Mao J, Dolman MEM, Zhao A, O'Regan LP, Gorgels D, Lau LMS, Ziegler DS, Haber M, Tyrrell V, Lock RB, Cowley MJ, Nicholls W, Daly RJ, Ekert PG, Fleuren EDG.   +33 more
europepmc   +1 more source

Molecular Classifications and Candidate Biomarkers for Personalizing BCG Therapy in Non-Muscle-Invasive Bladder Cancer. [PDF]

Biomedicines
Bilyalov A, Kotov A, Bodunova N, Zingerenko M, Khatkov I, Zhukova L.   +5 more
europepmc   +1 more source